International Journal of Molecular Medical Science, 2025, Vol.15, No.6, 287-297 http://medscipublisher.com/index.php/ijmms 295 Chermahini F., Arvejeh P., Marincola F., Ahmad S., Naderian R., Pajand O., Eslami M., Hasannia M., and Sanami S., 2025, Investigating how dengue virus-induced metabolic changes affect the host immune response and how to develop Immunomodulatory strategies, Virology Journal, 22(1): 117. https://doi.org/10.1186/s12985-025-02745-3 Cloherty A., Rader A., Patel K., Eisden T., Van Piggelen S., Schreurs R., and Ribeiro C., 2024, Dengue virus exploits autophagy vesicles and secretory pathways to promote transmission by human dendritic cells, Frontiers in Immunology, 15: 1260439. https://doi.org/10.3389/fimmu.2024.1260439 Dash M., Samal S., Rout S., Behera C., Sahu M., and Das B., 2024, Immunomodulation in dengue: towards deciphering dengue severity markers, Cell Communication and Signaling, 22(1): 451. https://doi.org/10.1186/s12964-024-01779-4 De Sousa F., Biering S., Patel T., Blanc S., Camelini C., Venzke D., Nunes R., Romano C., Beatty P., Sabino E., and Harris E., 2022, Sulfated β-glucan from Agaricus subrufescens inhibits flavivirus infection and nonstructural protein 1-mediated pathogenesis, Antiviral Research, 203: 105330. https://doi.org/10.1016/j.antiviral.2022.105330 Estrada-Jiménez T., Flores-Mendoza L., Ávila-Jiménez L., Vázquez-Rodríguez C., Sánchez-Burgos G., Vallejo-Ruíz V., and Reyes-Leyva J., 2022, Low activation of CD8+T Cells in response to viral peptides in mexican patients with severe dengue, Journal of Immunology Research, 2022(1): 9967594. https://doi.org/10.1155/2022/9967594 Fernandes-Santos C., and Azeredo E., 2022, Innate immune response to dengue virus: toll-like receptors and antiviral response, Viruses, 14(5): 992. https://doi.org/10.3390/v14050992 Ghosh P., Saha B., Kaveri K., and Tripathi A., 2024, Significance of diagnostic and therapeutic potential of serum endothelial and inflammatory biomarkers in defining disease severity of dengue infected patients, Medical Microbiology and Immunology, 214(1): 3. https://doi.org/10.1007/s00430-024-00810-2 Hasani S., Sgroi G., Esmaeilnejad B., Nofouzi K., Mahmoudi S., Shams N., Samiei A., and Khademi P., 2025, Recent advances in the control of dengue fever using herbal and synthetic drugs, Heliyon, 11(3): e41939. https://doi.org/10.1016/j.heliyon.2025.e41939 Jeng M., Lee N., Lee I., Chen Y., Huang W., Hsu J., Tai C., and Lan H., 2025, Prognosis and mortality risk in elderly patients with dengue virus infection: excess fatality and the urgent need for revising current WHO criteria for elderly patients, Travel Medicine and Infectious Disease, 65: 102855. https://doi.org/10.1016/j.tmaid.2025.102855 Jiravejchakul N., Chan-In W., Thuncharoen W., Sakuntabhai A., Singhasivanon P., Suraamornkul S., Yingtaweesak T., Manopwisedjaroen K., Pitabut N., Thaloengsok S., Duangchinda T., Pakchotanon P., Sungnak W., Charoensawan V., Vacharathit V., and Matangkasombut P., 2025, Cytokine and chemokine kinetics in natural human dengue infection as predictors of disease outcome, Scientific Reports, 15(1): 15612. https://doi.org/10.1038/s41598-025-99628-y Kadi M., Yamashita M., Shimojima M., Yoshikawa T., Ebihara H., Okuzaki D., and Kurosu T., 2025, Cytokine storm and vascular leakage in severe dengue: insights from single-cell RNA profiling, Life Science Alliance, 8(6): e202403008. https://doi.org/10.26508/lsa.202403008 Katz R., Nam N., De Lima Campos T., Indenbaum V., Terenteva S., Hang D., Hoi L., Danielli A., Lustig Y., Schwartz E., Van Tong H., and Sklan E., 2025, Circulating lncRNAs as biomarkers for severe dengue using a machine learning approach, The Journal of Infection, 90(4): 106471. https://doi.org/10.1016/j.jinf.2025.106471 Khanam A., Gutiérrez-Barbosa H., Lyke K., and Chua J., 2022, Immune-mediated pathogenesis in dengue virus infection, Viruses 14(11): 2575. https://doi.org/10.3390/v14112575 Kurosu T., Sakai Y., Ami Y., Shimojima M., Yoshikawa T., Fukushi S., Nagata N., Suzuki T., Ebihara H., and Saijo M., 2024, Mice myeloid cells and dengue: a new model for unraveling vascular leakage mysteries, Frontiers in Microbiology 15: 1367672. https://doi.org/10.3389/fmicb.2024.1367672 Lim S., Gan S., Ong H., and Ngeow Y., 2024, In vitro analysis of VEGF-mediated endothelial permeability and the potential therapeutic role of Anti-VEGF in severe dengue, Biochemistry and Biophysics Reports, 39: 101814. https://doi.org/10.1016/j.bbrep.2024.101814 Limothai U., Jantarangsi N., Suphavejkornkij N., Tachaboon S., Dinhuzen J., Chaisuriyong W., Trongkamolchai S., Wanpaisitkul M., Chulapornsiri C., Tiawilai A., Tiawilai T., Tantawichien T., Thisyakorn U., and Srisawat N., 2022, Discovery and validation of circulating miRNAs for the clinical prognosis of severe dengue, PLoS Neglected Tropical Diseases, 16(10): e0010836. https://doi.org/10.1371/journal.pntd.0010836 Mahashabde M., and Kumar L., 2024, Integrated approach to severe dengue complicated by Guillain-Barré syndrome and multi-organ failure, Cureus, 16(7): e63939. Masyeni S., Wardhana M., and Nainu F., 2024, Cytokine profiles in dengue fever and dengue hemorrhagic fever: a study from indonesia, Narra J., 4(1): e309. https://doi.org/10.52225/narra.v4i1.309 McBride A., Duyen H., Vuong N., Tho P., Tai L., Phong N., Ngoc N., Yen L., Nhat P., Vi T., Llewelyn M., Thwaites L., Van Hao N., and Yacoub S., 2024, Endothelial and inflammatory pathophysiology in dengue shock: New insights from a prospective cohort study in Vietnam, PLOS Neglected Tropical Diseases, 18(3): e0012071. Méndez G., Salmanton-García J., Niveyro C., Villalba P., Martin V., Compañy L., Tomasino M., Ferreyra C., Pelech F., Kuo L., Irala F., Davalos C., Veronesi C., Varas A., Cornely O., and Salvatierra K., 2025, P-159., Epidemiological and clinical characteristics of dengue fever in patients admitted at a universitary hospital, Open Forum Infectious Diseases, 12(Suppl 1): ofae631-364.
RkJQdWJsaXNoZXIy MjQ4ODYzNA==